Stay informed with expert insights, trends, and best practices in life sciences compliance.
qordata hosted a webinar with Seth Lundy and Brian Bohnenkamp from King & Spalding to keep the compliance community updated with recent changes in PhRMA Code and the implications on life sciences compliance after those revisions. A number of questions were raised in our webinar that Seth and Brian tried to answer. Here’s a summary […]
On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released highly anticipated revisions to its Code on Interactions with Health Care Professionals, effective January 1, 2022. In order to keep our compliance community updated with these changes, qordata collaborated with Seth Lundy and Brian Bohnenkamp from King & Spalding to bring forth […]
AUGUST 17th, NEW JERSEY: New Jersey-based compliance solutions and IT consulting services provider qordata has made it to Inc. 5000’s 2021 list as one of the fastest-growing private companies in the US. As the Inc. 5000 formally announced this year’s list, qordata has achieved the 1351st spot. The Inc. 5000 lists the 5,000 fastest-growing private […]
The Open Payments program is a transparency program that provides clarity between Pharmaceutical Manufacturers and the payments they make to healthcare providers and teaching hospitals. As Pharmaceutical Manufacturers, Open Payments require you to report all direct and indirect payments or transfers of values made to physicians, teaching hospitals, and basically anyone in the healthcare sector […]
In November 2020, The United States Department of Health and Human Services Office of Inspector General (OIG) issued a “Special Fraud Alert: Speaker Programs“. The Special Fraud Alert highlights the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to speaker programs by life sciences companies. It raises questions […]
qordata hosted an interactive webinar with Sarah DiFransesca from Dinsmore & Shohl LLP and Leslie Restanio from Amneal Pharmaceuticals for analyzing the recently rolled out OIG’s Special Fraud Alert for Speaker Programs. The Special Fraud Alert highlights the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to speaker […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 0. All rights reserved | Sitemap | Privacy Policy | Terms of Use